Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 8/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CTSD | P07339 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29818654 | 0.94 | LTA4H (0.61) | LTA4HKCNH2CTSDMAPTNPC1 | |
| SCHEMBL9499089 | 0.88 | NPC1 (0.52) | LTA4HKCNH2MAPTNPC1RAB9A | |
| SCHEMBL29818612 | 0.86 | LTA4H (0.54) | LTA4HKCNH2CTSDMAPTNPC1 | |
| SCHEMBL28437684 | 0.86 | LTA4H (0.54) | LTA4HKCNH2CTSDMAPTNPC1 | |
| SCHEMBL28437938 | 0.86 | LTA4H (0.54) | LTA4HKCNH2TDP1L3MBTL1CTSD | |
| SCHEMBL28435756 | 0.86 | LTA4H (0.54) | LTA4HKCNH2TDP1L3MBTL1CTSD | |
| SCHEMBL8688782 | 0.86 | LTA4H (0.54) | LTA4HKCNH2CTSDMAPTNPC1 | |
| SCHEMBL8688786 | 0.86 | LTA4H (0.54) | LTA4HKCNH2MAPK1CTSDMAPT | |
| SCHEMBL14542334 | 0.86 | LTA4H (0.54) | LTA4HKCNH2MAPK1CTSDMAPT | |
| SCHEMBL29818690 | 0.86 | LTA4H (0.54) | LTA4HKCNH2TDP1L3MBTL1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 716 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12635409-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-05-19 | — | — | US | disclosed |
| US-12615957-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-04-28 | — | — | US | disclosed |
| EP-3968404-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2026-04-01 | — | — | EP | disclosed |
| US-20260090262-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4701391-A2 | HETEROLEPTIC IRIDIUM COMPLEX | Universal Display Corporation (US) | 2026-02-25 | — | — | EP | disclosed |
| US-12550604-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-02-10 | — | — | US | disclosed |
| EP-3643721-B1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORP (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12527214-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-01-13 | — | — | US | disclosed |
| EP-4167707-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2025-12-10 | — | — | EP | disclosed |
| US-20250359473-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERAL DISPLAY CORPORATION (US) | 2025-11-20 | — | — | US | disclosed |
| EP-0907650-B1 | N- 4-(HETEROARYLMETHYL)PHENYL]-HETEROARYLAMINES | JANSSEN PHARMACEUTICA NV (BE) | 2002-12-04 | — | — | EP | disclosed |
| US-6486187-B1 | N-[4-(heteroarylmethyl)phenyl]-heteroarylamines | JANSSEN PHARMACEUTICA N.V. (BE) | 2002-11-26 | — | — | US | disclosed |
| WO-2001087828-A1 | N-SUBSTITUTED PEPTIDYL NITRILES AS CYSTEINE CATHEPSIN INHIBITORS | NOVARTIS AG (CH) | 2001-11-22 | — | — | WO | disclosed |
| US-6124330-A | A RETINOIC MIMETIC COMPOUND FOR TREATING A WARM-BLOODED ANIMAL SUFFERING FROM A DISEASE BY AN ABNORMAL PROLIFERATION AND/OR ABNORMAL DIFFERENTIATION OF NORMAL, PRENEOPLASTIC OR NEOPLASTIC CELLS | JANSSEN-CILAG S.A. (FR) | 2000-09-26 | — | — | US | disclosed |
| EP-0907650-A1 | N- 4-(HETEROARYLMETHYL)PHENYL]-HETEROARYLAMINES | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997049704-A1 | N-[4-(HETEROARYLMETHYL)PHENYL]-HETEROARYLAMINES | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-12-31 | — | — | WO | disclosed |
| US-4888041-A | POST EMERGENCE HERBICIDES | THE DOW CHEMICAL COMPANY (US) | 1989-12-19 | — | — | US | disclosed |
| EP-0245804-A3 | HERBICIDALLY ACTIVE SUBSTITUTED PHENOXY BENZOXAZOLE (OR BENZOTHIAZOLE) COMPOUNDS | PPG INDUSTRIES, INC. (US) | 1988-06-08 | — | — | EP | disclosed |
| US-4746351-A | POSTEMERGENCE | PPG INDUSTRIES, INC. (US) | 1988-05-24 | — | — | US | disclosed |
| EP-0245804-A2 | Herbicidally active substituted phenoxy benzoxazole (or benzothiazole) compounds | PPG INDUSTRIES, INC. (US) | 1987-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12615957-B2 | Organic electroluminescent materials and devices | LBR, NR4A1, MLX | LTA4H 2072/4885KCNH2 1131/4885MAPK1 2128/4885 |
| US-12635409-B2 | Organic electroluminescent materials and devices | NSUN2, CTNND1, NSD1 | LTA4H 865/4885KCNH2 28/4885MAPK1 2667/4885 |
| US-20260090262-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | TLL1, TLL2, LAS1L | LTA4H 1043/4885KCNH2 224/4885MAPK1 1951/4885 |
| US-20250359473-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | LTA4H 2372/4885KCNH2 599/4885MAPK1 3880/4885 |
| US-12550604-B2 | Organic electroluminescent materials and devices | ROS1, DNMT3A, PRDM9 | LTA4H 4508/4885KCNH2 369/4885MAPK1 1273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.